Companies Dominating the Oncology Imaging Software Landscape
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Step-Pharma
- Novartis A.G.
- Abbott
- Amgen Inc.
- Biogen
- Johnson & Johnson
- Merck & Co.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of oncology imaging software is evaluated at USD 4.44 billion.
The oncology imaging software market size was over USD 4.24 billion in 2024 and is poised to exceed USD 8.93 billion by 2037, witnessing over 5.9% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of cancer worldwide will drive the market growth.
North America industry is expected to account for largest revenue share of 41% by 2037, owing to increasing demand for oncology imaging software in this region.
The major players in the market include Pfizer Inc., Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsStep-Pharma, Novartis A.G., Abbott, Amgen Inc., Biogen, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Hoffmann-La Roche Ltd.
